USPTO serial 79256575
D DATAVANT
Reviewed by CopyMark Law Group
Reg. 6026113Status 709
- Filing date
- Status date
- Registration date
- Apr 7, 2020
- Examiner
- MARTINS, ODETTE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with D DATAVANT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Vanessa A. Ignacio, Esq.
Vanessa A. Ignacio, Esq. Lowenstein Sandler LLPOne Lowenstein DriveRoseland, NJ 07068United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for transmitting, analyzing and generating reports; downloadable Computer software for data processing in the field of healthcare, biomedical research, and clinical trial data; Downloadable computer software for providing, analyzing and generating reports in the field of healthcare, biomedical research, and clinical trial data; Downloadable computer software for data processing; Downloadable computer programs and computer operating systems for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; Downloadable computer programs and computer operating systems for the conversion, analysis, processing, storage and transmission of artificial intelligence; Downloadable artificial intelligence and machine learning software for statistical analysis, consultancy and reporting; Downloadable software for analytics in the field of public health, healthcare, pharmaceuticals, biotechnology, biomedical research and development, clinical trials as well as post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; Downloadable software for data linkage, discovery, and de-identification used in the fields of healthcare, biomedical research, and clinical trial data for the provision of medical services, public health services and healthcare services; Downloadable computer software for database integration; Downloadable computer software for creating searchable databases of information and data; Downloadable computer software featuring an electronic computer database for linking, viewing, and de-identifying healthcare and healthcare related data used in the field of healthcare, biomedical research, and clinical trial data; Downloadable computer software for accessing data and information related to healthcare services, patient medical information and clinical trial data and for controlling and managing data and information related to healthcare services, patient medical information and clinical trial data; none of the foregoing directly related to video surveillance or video based security apparatus | SECTION 71 - CANCELLED | — |
| 035 | Advertising; business management; business administration; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; business data analysis and professional business consultancy services regarding statistics for biomedical research, healthcare institutions and healthcare professionals, based on artificial intelligence and machine learning; business analysis and statistical analysis of healthcare data, biomedical research and clinical trial data; systematization and compilation of data in computer databases; compilation of information into computer databases for research and analysis purposes in the fields of public health, healthcare, biomedicine, biotechnology, pharmaceuticals, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research, pharmacoepidemiological research and research evaluating epidemiological outcomes; professional business analysis, business consultancy and statistical analysis for business purposes in the fields of public health, healthcare, pharmaceuticals, biotechnology, biomedical research and developments, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research, pharmacoepidemiological research and research evaluating epidemiological outcomes | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services, namely, medical research and scientific research, chemical analysis in the healthcare and biomedical field; Scientific research; Chemical analysis for industrial purposes; Biomedical research services; Design and development of computer software; Cloud computing featuring software for de-identifying, linking, and analyzing data used in the field of healthcare, biomedical research, and clinical trial data; Scientific data processing analysis services; Pharmaceutical and biomedical research services, conducting clinical trials for others, post-authorization research for the marketing of medicines and commercial post-launching of medicines, epidemiological research, pharmacoepidemiological research and research evaluating epidemiological outcomes; Providing temporary use of non-downloadable software applications accessible via a web site for de-identifying, linking, and analyzing data used in the field of healthcare, biomedical research, and clinical trial data regarding analytics in the fields of public health, healthcare, pharmaceuticals, biomedical research and clinical trial data; Providing temporary use of non-downloadable software applications accessible via a web site for de-identifying, linking, and analyzing data used in the field of healthcare, biomedical research, and clinical trial data regarding information in the fields of public health, healthcare, pharmaceuticals, biomedical research and clinical trials; Providing temporary use of non-downloadable software applications accessible via a web site for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; Providing temporary use of non-downloadable software applications accessible via a web site for de-identifying, linking, and analyzing data used in the field of healthcare, biomedical research, and clinical trial data regarding data in the fields of public health, healthcare, pharmaceuticals, biomedical research, patient data, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research and pharmacoepidemiological research; Providing technological online information in the fields of public health, healthcare, pharmaceuticals, patient data, biomedical research, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines from a computer database or the Internet; Providing scientific online information online in the fields of public health, healthcare, pharmaceuticals, patient data, biomedical research, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines from a computer database or the Internet; Providing scientific research information in the field of biomedicine, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; Scientific analysis in the field of scientific data relating to biomedical research and clinical trials; Research and analysis services in the scientific fields of artificial intelligence and machine learning analytics for biomedical research and healthcare institutions | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Roivant Sciences GmbH
- Other trademarks owned by Datavant, Inc.
- Other trademarks owned by Datavant, Inc.
- Other trademarks owned by Datavant, Inc.
- Other trademarks owned by Datavant, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named D DATAVANT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 23, 2026 | C71T | CANCELLED SECTION 71 | — |
| Dec 18, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 18, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 18, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 18, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 18, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 15, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 7, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 29, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 5, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 14, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 14, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 7, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 7, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 21, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 21, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 17, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 1, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 1, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 1, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 17, 2019 | ALIE | ASSIGNED TO LIE | — |
| Dec 14, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 13, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 13, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 13, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 13, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 3, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 3, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 3, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 3, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 13, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 13, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 13, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 13, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 31, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 16, 2019 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Oct 12, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 12, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 12, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 12, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 16, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 16, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 8, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 26, 2019 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jul 10, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 10, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 28, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 27, 2019 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jun 3, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 3, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 12, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 11, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 7, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 3, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 3, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 2, 2019 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 18, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |